Sickle cell anemia (SCA) is one of the most common inherited blood disorders in the world, characterized by chronic hemolytic anemia and recurrent vasoocclusive pain episodes. Pulmonary complications are a… Click to show full abstract
Sickle cell anemia (SCA) is one of the most common inherited blood disorders in the world, characterized by chronic hemolytic anemia and recurrent vasoocclusive pain episodes. Pulmonary complications are a major cause of morbidity and mortality. Individuals with SCA have been shown to have a high prevalence of asthma, wheezing, and airway hyperresponsiveness (AHR) (1, 2). Increased AHR has been demonstrated in individuals with SCA, both with and without a concomitant diagnosis of asthma (2, 3). Although previous studies have looked at the association between a history of acute chest syndrome (ACS) episodes and AHR to methacholine (4), investigators have not examined whether AHR to methacholine is a risk factor for future SCA-related morbidity (pain and ACS). Therefore, the aim of this study was to examine the association between AHR to methacholine and future rates of hospitalization for pain and ACS.
               
Click one of the above tabs to view related content.